Using a closure analysis method to reduce CGT contamination risks
Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contam...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions for industry adoption? Where can you learn about benchmarking exercises, feedba...
Why this SUS audit guide will reduce industry’s audit burden
In 2020, BioPhorum and Rx-360™ collaborated to develop a pilot program to assess that a Joint Audit Program® model wa...
How to introduce new materials – one gate at a time
There are many challenges during drug substance supply in a biopharmaceutical new product introduction (NPI) process. Cl...
Understanding the industry baseline for electronic data exchange implementation across the inbound supply chain
Digitization has transformed both our domestic and commercial lives, and the rapid change we have seen since the introdu...
Forecasting the future with BioPhorum’s accuracy calculator
Generating forecasts remains a thorny problem for many companies who often find the increased demand on the in-bound sup...
‘From grass to glass’: how BioPhorum’s Strategic Framework will influence the whole in-bound supply chain
Covid-19 has not only highlighted the criticality of the in-bound supply chain but some of the long-standing, systemic f...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...
How to master virtual inspections and audits – learning from experience
In normal conditions, regulatory inspections and audits are conducted on-site, with inspectors viewing operations, talki...
Demonstrating the utility of a joint audit approach
An inefficiency in our industry is where multiple manufacturers individually audit the same supplier in the same year or...
How industry is reacting to the Covid-19 pandemic
LONG READHow industry is reacting to the Covid-19 pandemicKeeping in touch with peers and colleagues has never been...
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Where can you read about industry trends, progress against shared challenges, and best practice solutions...
Why this SUS audit guide will reduce industry’s audit burden
In 2020, BioPhorum and Rx-360™ collaborated to develop a pilot program to assess that a Joint Audit Program® model wa...
How to introduce new materials – one gate at a time
There are many challenges during drug substance supply in a biopharmaceutical new product introduction (NPI) process. Cl...
Understanding the industry baseline for electronic data exchange implementation across the inbound supply chain
Digitization has transformed both our domestic and commercial lives, and the rapid change we have seen since the introdu...
Forecasting the future with BioPhorum’s accuracy calculator
Generating forecasts remains a thorny problem for many companies who often find the increased demand on the in-bound sup...
‘From grass to glass’: how BioPhorum’s Strategic Framework will influence the whole in-bound supply chain
Covid-19 has not only highlighted the criticality of the in-bound supply chain but some of the long-standing, systemic f...
BioPhorum launch new sustainability phorum
BioPhorum members have given us a clear message; to be an industry that supports sustainability is extremely important t...
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...
Overcoming unique challenges to support rapid development of diverse products
LONG READOvercoming unique challenges to support rapid development of diverse productsThe Cell and Gene Therapy (CGT)...
The Power of Industry Collaboration: Driving Harmonization of Regulatory Requirements
Driving the harmonization of regulatory requirements – one country at a time Regulations play a significant role...
How to master virtual inspections and audits – learning from experience
In normal conditions, regulatory inspections and audits are conducted on-site, with inspectors viewing operations, talki...
Demonstrating the utility of a joint audit approach
An inefficiency in our industry is where multiple manufacturers individually audit the same supplier in the same year or...